Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2245116

N.N.O=C(O)CC[C@H](NC(C(=O)O)C(=O)O)C(=O)O.[Fe]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.55
NAALAD2 Q9Y3Q0 3/20 0.55
RIMKLA Q8IXN7 1/20 0.55
GGH Q92820 2/20 0.47
TET2 Q6N021 3/20 0.41
KDM4A O75164 2/20 0.41
KDM4C Q9H3R0 2/20 0.41
KDM2A Q9Y2K7 2/20 0.41
TET3 O43151 1/20 0.41
CYP1A2 P05177 2/20 0.40
GRM8 O00222 1/20 0.40
GRM6 O15303 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GSR P00390 1/20 0.40
GRIK1 P39086 1/20 0.40
GRM5 P41594 1/20 0.40
GRIA1 P42261 1/20 0.40
GRIA2 P42262 1/20 0.40
GRIA3 P42263 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL275442 1.00 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
Ammonia Solution, Strong SCHEMBL2150080 1.00 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
Ammonia Solution, Strong SCHEMBL3695091 0.98 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
Ammonia Solution, Strong SCHEMBL3695087 0.98 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
Ammonia Solution, Strong SCHEMBL3695083 0.98 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL275407 0.96 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL275405 0.96 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL136061 0.96 FOLH1 (0.59) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL136060 0.96 FOLH1 (0.59) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL1653628 0.94 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9730904-B2 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient SBI PHARMACEUTICALS CO., LTD. (JP) 2017-08-15 US claimed
US-20150290159-A1 PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OF 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT SBI PHARMACEUTICALS CO., LTD. (JP) 2015-10-15 US claimed
EP-3192506-A2 PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OR 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT SBI Pharmaceuticals Co., Ltd. (JP) 2017-07-19 EP disclosed
EP-2340821-B1 PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OF 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT SBI PHARMACEUTICALS CO LTD (JP) 2017-01-25 EP disclosed
US-9095165-B2 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient SBI PHARMACEUTICALS CO., LTD. (JP) 2015-08-04 US disclosed
US-20110196033-A1 PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OR 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT SBI ALAPROMO CO., LTD. (JP) 2011-08-11 US disclosed